Malignant Fibrous Histiocystoma Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Histiocytosis Program

Summary

Boston Children's Hospital and Dana-Farber Cancer Institute are also conducting numerous research studies to help better understand and treat soft tissue and bone sarcomas.

Research Underway

Types of treatment currently being studied include:

  • We are studying angiogenesis inhibitors, substances that may be able to prevent the growth of tumors.
  • We are also studying biological therapies, a wide range of substances that may be able to involve the body's own immune system to fight cancer or lessen harmful side effects of some treatments.
  • Researchers are looking into neoadjuvant chemotherapy and radiotherapy, treatments using chemotherapy and radiotherapy before resecting the primary tumor are being investigated.
Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337

Close